lm 4108 and celecoxib

lm 4108 has been researched along with celecoxib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, LC; Chen, CS; Cheng, FC; Chern, JW; Huang, CH; Tan, CM; Wang, JP	1

Other Studies

1 other study(ies) available for lm 4108 and celecoxib

Article	Year
Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production. Bioorganic & medicinal chemistry, 2010, Jan-15, Volume: 18, Issue:2 Topics: Animals; Benzothiazoles; Cell Line; Crystallography, X-Ray; Cyclic S-Oxides; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Discovery; Humans; Lipoxygenase Inhibitors; Mice; Models, Molecular; Molecular Structure; Nitro Compounds; Structure-Activity Relationship; Thiazoles; Tumor Necrosis Factor-alpha	2010

Article

Year

Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.

Bioorganic & medicinal chemistry, 2010, Jan-15, Volume: 18, Issue:2

Topics: Animals; Benzothiazoles; Cell Line; Crystallography, X-Ray; Cyclic S-Oxides; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Discovery; Humans; Lipoxygenase Inhibitors; Mice; Models, Molecular; Molecular Structure; Nitro Compounds; Structure-Activity Relationship; Thiazoles; Tumor Necrosis Factor-alpha

2010